These facts are updated till 25 Jan 2024, and are based on Volza'sIndia Import data India Import data of HSN Code 30049099 sourced from 70 countries export import shipments with names of buyers, suppliers, top Decision maker's contact information like Direct, phone, email and LinkedIn profiles.
HSN Code | Product Description | Origin | Destination | Qty. | Importer | Exporter |
---|
30049099 | TABLETS >> JNJ-54861911-AAA 25MG TABLETS IMP TEST LIC. NO. T-8848-13 DT 30.09.13 FOR R & D UNIT ONLY | Belgium | India | 2000 | |||
30049099 | INDIA >> TRPAT INDIA DUROGESIC D-TRANS 50MU 3 TRPAT INDIA | Belgium | India | 75 | |||
30049099 | OLICLINOMEL >> OLICLINOMEL N7-1000 E 1500 ML | Belgium | India | 772 | |||
30049099 | CLINICAL >> CLINICAL TRIAL JNJ28431754 100MG , 300MG-PLACEBO PER 1KIT = 55 CAPSULE IMPT LIC.#.101-CT-BE-13 DT.08-07-2013 FOR CLINICAL TRIAL USE O | Belgium | India | 44 | |||
30049099 | CLINICAL >> CLINICAL TRIAL JNJ28431754 100MG , 300MG-PLACEBO PER 1KIT = 55 CAPSULE IMPT LIC.#.101-CT-BE-13 DT.08-07-2013 FOR CLINICAL TRIAL USE O | Belgium | India | 22 | 60 More Columns Available | ||
30049099 | OLICLINOMEL >> OLICLINOMEL N7-1000 E 1500 ML | Belgium | India | 228 | |||
30049099 | INDIA >> SYR INDIA INV.EGA SUSTENNA 1X100MG SYR.INDIA | Belgium | India | 200 | |||
30049099 | SOLUTION >> VIAL SOLUTION NOOTROPIL 2G PER VIAL SOLUTION FOR INJECTIONS IMP TEST LICNO.T-6587-13 DT.03.08.2013 FOR TESTING PURPOSE ONLY | Belgium | India | 79 | |||
30049099 | TABLET >> CITRIZINE TABLET ZYRTEC CITRIZINE TABLET 100MG IMP TEST LIC NO.T-5687-13 DT.10.07.2013 FOR TESTING PURPOSE ONLY | Belgium | India | 920 | |||
30049099 | TABLETS >> ATARAX 10MG FILM-COATED TABLETS IMP TEST LIC NO.T-6587-13 DT.03.08.2013 FOR TESTING PURPOSE ONLY | Belgium | India | 2275 | |||
30049099 | TABLETS >> ATARAX 10MG FILM-COATED TABLETS IMP TEST LIC NO.T-6587-13 DT.03.08.2013 FOR TESTING PURPOSE ONLY | Belgium | India | 5711 | |||
30049099 | SOLUTION >> ORAL SOLUTION XYZAL LEVOCETIRIZINE ORAL SOLUTION 0.5MG-ML T-11260-13 DT.05.12.2013 FOR TESTING PUROPSE ONLY | Belgium | India | 19 | |||
30049099 | SOLUTION >> ORAL SOLUTION ZYRTEC CETRIZINE ORAL SOLUTION 1MG-ML T-11260-13 DT.05.12.2013 FOR TESTING PUROPSE ONLY | Belgium | India | 15 | |||
30049099 | INDIA >> VIAL INDIA DACOGEN IV 1X50MG VIAL INDIA | Belgium | India | 18 | |||
30049099 | TABLETS >> CANDESARTAN TABLETS ATACAND CANDESARTAN TABLETS 8MG 56 TABLETS-PACK ASTRA ZE - NECA LICENCENO.T-4088-14.DTD: 22-05-2014 SAMPLE FOR R & D | Belgium | India | 2 | |||
30049099 | OLICLINOMEL >> OLICLINOMEL N4-550 E 1000ML | Belgium | India | 42 | |||
30049099 | INDIA >> TRPAT INDIA DUROGESIC D-TRANS 50MU 3 TRPAT INDIA | Belgium | India | 7000 | |||
30049099 | PIPAMPERONE >> DIPIPERON PIPAMPERONE DIPIPERON PIPAMPERONE HCL 4MG-ML IMP TEST LIC NO.T-1516-14DT.25.03.2014 FOR TESTING PURPOSE ONLY | Belgium | India | 32 | |||
30049099 | DROPS >> ORAL DROPS ZYRTEC ORAL DROPS CETRIZINE 5MG-ML T-11260-13 DT.05.12.2013 FOR TESTING PUROPSE ONLY | Belgium | India | 15 | |||
30049099 | INDIA >> SYR INDIA INV.EGA SUSTENNA 1X75MG SYR. INDIA | Belgium | India | 200 | |||
30049099 | SOLUTION >> ORAL SOLUTION ZYRTEC CETRIZINE ORAL SOLUTION 1MG-ML T-11260-13 DT.05.12.2013 FOR TESTING PUROPSE ONLY | Belgium | India | 30 | |||
30049099 | INDIA >> VIAL INDIA VELCADE 1X3.5MG VIAL INDIA | Belgium | India | 288 | |||
30049099 | CLINDAMYCIN >> DALACIN C SSOL 600MG 1X4 ML LIST 3 SR NO.18 CLINDAMYCIN | Belgium | India | 127440 | |||
30049099 | INDIA >> SYR INDIA INV.EGA SUSTENNA 1X75MG SYR. INDIA | Belgium | India | 200 | |||
30049099 | CLINICAL >> CLINICAL TRIAL JNJ28431754 100MG , 300MG-PLACEBO PER 1KIT = 55 CAPSULE IMPT LIC.#.101-CT-BE-13 DT.08-07-2013 FOR CLINICAL TRIAL USE O | Belgium | India | 49 | |||
30049099 | CLINICAL >> CLINICAL TRIAL JNJ28431754 100MG , 300MG-PLACEBO PER 1KIT = 55 CAPSULE IMPT LIC.#.101-CT-BE-13 DT.08-07-2013 FOR CLINICAL TRIAL USE O | Belgium | India | 127 | |||
30049099 | SOLUTION >> RITONAVIR 80MG-ML 1X90ML SOLUTION FOR ORAL USE | Belgium | India | 3 | |||
30049099 | DROPS >> ORAL DROPS ZYRTEC ORAL DROPS CETRIZINE 5MG-ML T-11260-13 DT.05.12.2013 FOR TESTING PUROPSE ONLY | Belgium | India | 68 | |||
30049099 | BOTTLE >> BOTTLE HALOPERIDOL HALDOL BOTTLE HALOPERIDOL 2 MG-ML 1BOTTLE-100ML IMP TEST LIC NO.T-1562-14 DT.01.04.2014 FOR TESTING PURPOSE ONLY | Belgium | India | 41 | |||
30049099 | SUSPENSION >> INJECTABLE SUSPENSION PALIPERIDONE PALMITATE INV.EGA SUSTENNA 117 MG FOR EXTENDED RELEASE INJECTABLE SUSPENSION 30 PREFILLED SINGLE-USE SYRI | Belgium | India | 30 | |||
30049099 | OLICLINOMEL >> OLICLINOMEL N4-550 E 2000ML | Belgium | India | 1040 | |||
30049099 | TABLETS >> TABLETS GLIBENCLAMID DAONIL 5MG -100 TABLETS -GLIBENCLAMID LICENCE NO:T9361-13 D - TD:21-10-13 SAMPLE FOR R & D PURPOSE ONLY | Belgium | India | 1 | |||
30049099 | TABLETS >> LEVOFLOXACIN TABLETS AGILEV LEVOFLOXACIN TABLETS 500MG-5 TABLETS SAMPLE FOR R & - D PURPOSE ONLY | Belgium | India | 63 | |||
30049099 | CLINDAMYCIN >> DALACIN C SSOL 300MG 1X2ML AMP LIST 3 SR NO.18 CLINDAMYCIN | Belgium | India | 108688 | |||
30049099 | OPTH >> XALATAN OPTH XALATAN OPTH 1 X 2.5ML LATANOPROST - LIST 3 SL NO.46 | Belgium | India | 23070 | |||
30049099 | SUSTENNA >> INV.EGA SUSTENNA 1X150MG SYR | Belgium | India | 200 | |||
30049099 | SUSPENSION >> DOMPERIDONE SUSPENSION MOTILIUM BOTTLE -DOMPERIDONE SUSPENSION 1MG-ML UNDER TLIC NO.T-1567-14 DT.05.09.2014 FOR TESTING PURPOSE ONLY | Belgium | India | 60 | |||
30049099 | INDIA >> SYR INDIA INV.EGA SUSTENNA 1X100MG SYR. INDIA | Belgium | India | 610 | |||
30049099 | MEDROL >> SOLU MEDROL SOLU-MEDROL AOV 40MG 1ML LIST NO:3 SR NO 51 METHYLPRED | Belgium | India | 139146 | |||
30049099 | SUSPENSION >> TMC 114 DARUNAVIR 100MG-ML 1X200 ML SUSPENSION FOR ORAL USE | Belgium | India | 8 | |||
30049099 | TABLET >> TABLET INTELENCE TABLET INTELENCE ETRAVIRINE 100MG - 360 TABS. IN 3 KITS-FO - R PERSONAL USE ONLY PERISHABLE CARGO | Belgium | India | 3 | |||
30049099 | CLINICAL >> CLINICAL TRIAL JNJ28431754 100MG , 300MG-PLACEBO PER 1KIT = 55 CAPSULE IMPT LIC.#.101-CT-BE-13 DT.08-07-2013 FOR CLINICAL TRIAL USE O | Belgium | India | 167 | |||
30049099 | CLINICAL >> CLINICAL TRIAL JNJ28431754 100MG , 300MG-PLACEBO PER 1KIT = 55 CAPSULE IMPT LIC.#.101-CT-BE-13 DT.08-07-2013 FOR CLINICAL TRIAL USE O | Belgium | India | 117 | |||
30049099 | TUBES >> TUBES KETOCONAZOLE NIZORAL 20MG-G TUBES KETOCONAZOLE IMP TEST LIC NO.T-2484-13 DT.12.04.2013 FOR TESTING PURPOSE ONLY | Belgium | India | 10 | |||
30049099 | CLINICAL >> CLINICAL TRIAL JNJ28431754 100MG , 300MG-PLACEBO PER 1KIT = 55 CAPSULE IMPT LIC.#.101-CT-BE-13 DT.08-07-2013 FOR CLINICAL TRIAL USE O | Belgium | India | 46 | |||
30049099 | CLINICAL >> CLINICAL TRIAL JNJ28431754 100MG , 300MG-PLACEBO PER 1KIT = 55 CAPSULE IMPT LIC.#.101-CT-BE-13 DT.08-07-2013 FOR CLINICAL TRIAL USE O | Belgium | India | 30 | |||
30049099 | CLINICAL >> CLINICAL TRIAL JNJ28431754 100MG , 300MG-PLACEBO PER 1KIT = 55 CAPSULE IMPT LIC.#.101-CT-BE-13 DT.08-07-2013 FOR CLINICAL TRIAL USE O | Belgium | India | 20 | |||
30049099 | SOLUTION >> ORAL SOLUTION XYZAL LEVOCETRIZINE ORAL SOLUTION 0.5MG-ML IMP TEST LIC NO.T-11260-13 DT.05.12.2013 FOR TESTING PURPOSE ONLY | Belgium | India | 14 | |||
30049099 | CLINICAL >> CLINICAL TRIAL JNJ28431754 100MG , 300MG-PLACEBO PER 1KIT = 55 CAPSULE IMPT LIC.#.101-CT-BE-13 DT.08-07-2013 FOR CLINICAL TRIAL USE O | Belgium | India | 24 | |||
30049099 | CLINICAL >> CLINICAL TRIAL JNJ28431754 100MG , 300MG-PLACEBO PER 1KIT = 55 CAPSULE IMPT LIC.#.101-CT-BE-13 DT.08-07-2013 FOR CLINICAL TRIAL USE O | Belgium | India | 12 | |||
30049099 | N.C.V ATICAPRANT 10MG FILM COTED TABLETS JNJ-67953964-AAA G020 35 CT BLISTER81 BLISTERSFOR R&D UNIT ONLY | Belgium | India | 2835 | |||
30049099 | DUPILUMAB INJECTION DUPIXENT-200MG 175MG/ML-2X3=6 PENS-FOR TEST OR ANALYSIS PURPOSE ONLY | Belgium | India | 3 | |||
30049099 | PEMBROLIZUMAB INJECTION KEYTRUDA-25MG/ML ML-FOR TEST ORANALYSIS PURPOSE ONLY | Belgium | India | 6 | |||
30049099 | N.C.V LIVOCAB LEVOCABASTINE HCL 0.5 MG/ML NASAL SPRAY 1BOTTLE =15 ML 1500.ML FOR TESTING PURPOSE ONLY | Belgium | India | 100 | |||
30049099 | NCV-FOR CLINICAL TRIAL-AMIVANTAMAB 350 MG 50MG/ML IN A 7ML VIAL-FOR TESTING PURPOSE ONLY | Belgium | India | 10 | |||
30049099 | INVEGA SUSTENNA 1X150MG SYR 600 PCS | Belgium | India | 84 | |||
30049099 | INVEGA SUSTENNA 1X100MG SYR 1000 PCS | Belgium | India | 75.20 | |||
30049099 | NCV-FOR CLINICAL TRIAL-MACITENTAN 75MG/PLACEBO-36X6=216 TABS-FOR TESTING PURPOSE ONLY | Belgium | India | 6 | |||
30049099 | NCV-FOR CLINICAL TRIAL-MACITENTAN 37.5MG/PLACEBO-36X1=36 TABS-FOR TESTING PURPOSE ONLY | Belgium | India | 1 | |||
30049099 | NCV-FOR CLINICAL TRIAL-MACITENTAN 10MG/PLACEBO-36X7=252 TABS-FOR TESTING PURPOSE ONLY | Belgium | India | 7 | |||
30049099 | N.C.V NIZORAL 20MG/G CERAM 1 TUBE= 10G 840G FOR TESTING PURPOSE ONLY | Belgium | India | 84 | |||
30049099 | NEPAFENAC OPHTHALMIC SUSPENSION 0.3% W/V 3MG/ML LDPE 3ML XIN 753761 BATCH-VT610A IL/FF-000287 RC/FF-002118 VALID DAT | Belgium | India | 18318 | |||
30049099 | NEPAFENAC OPHTHALMIC SUSPENSION 0.3% W/V 3MG/ML LDPE 3ML XIN 753761 BATCH-VT610A IL/FF-000287 RC/FF-002118 VALID DAT | Belgium | India | 18318 | |||
30049099 | NEPAFENAC OPHTHALMIC SUSPENSION 0.3% W/V 3MG/ML LDPE 3ML XIN 753761 BATCH-VT610A IL/FF-000287 RC/FF-002118 VALID DAT | Belgium | India | 18318 | |||
30049099 | NEPAFENAC OPHTHALMIC SUSPENSION 0.3% W/V 3MG/ML LDPE 3ML XIN 753761 BATCH-VT610A IL/FF-000287 RC/FF-002118 VALID DAT | Belgium | India | 18318 | |||
30049099 | NEPAFENAC OPHTHALMIC SUSPENSION 0.3% W/V 3MG/ML LDPE 3ML XIN 753761 BATCH-VT610A IL/FF-000287 RC/FF-002118 VALID DAT | Belgium | India | 18318 | |||
30049099 | ONE ALPHA1MCG/ 30 X 23 PACKS ALPHACALCIDOL CAPSULE FOR RESERACH AND ANALYSIS PURPOSE ONLY | Belgium | India | 690 | |||
30049099 | CARTON CONTAINS 2 BLISTERS. BLISTER CONTAINS 15 TABLETS OF 25 MG EXEMESTANE. FOR ORAL USE ONLY. LOT: D594588 TOTAL 25 | Belgium | India | 68 | |||
30049099 | CARTON CONTAINS 2 BLISTERS. BLISTER CONTAINS 14 TABLETS OF 1 MG ANASTROZOLE. FOR ORAL USE ONLY. LOT: D534509 TOTAL QU | Belgium | India | 176 | |||
30049099 | N.C.V LAZERTINIB JNJ-73841937-ZCY 80MG TABLETS 60 X 56CT BOTTLE FOR R&D UNIT ONLY | Belgium | India | 3360 | |||
30049099 | METHYLPREDNISOLONE TABLET 32 MG MEDROL PACK SIZE: 20 TABLETS | Belgium | India | 5 | |||
30049099 | N.C.V LAZERTINIB JNJ-73841937-ZCY 240MG TABLETS 30 X 98CT BOTTLEFOR R&D UNIT ONLY | Belgium | India | 2940 | |||
30049099 | NCV-FOR CLINICAL TRIAL-MACITENTAN 10MG-36X4=144 TABS-FOR TESTING PURPOSE ONLY | Belgium | India | 4 | |||
30049099 | NCV-FOR CLINICAL TRIAL-AMIVANTAMAB 350MG/VIAL 50 MG/ML, 7ML AMIVANTAMAB-FOR TESTING PURPOSE ONLY | Belgium | India | 4 | |||
30049099 | ODEFSEY EMTRICITABINE,RILPIVIRINE & TENOFOVIR ALAFENAMIDE 200/25/25MG FILM-COTED TAB 6PACKSX30 COUNT 180 TAB FOC | Belgium | India | 6 | |||
30049099 | NCV-FOR CLINICAL TRIAL-MACITENTAN 10MG/PLACEBO-36X12=432 TABS-FOR TESTING PURPOSE ONLY | Belgium | India | 12 | |||
30049099 | NCV-FOR CLINICAL TRIAL-LAZERTINB 80 MILLIGRAM MG-72X4=288TABS-FOR TESTING PURPOSE ONLY | Belgium | India | 4 | |||
30049099 | NCV-FOR CLINICAL TRIAL-AMIVANTAMAB 350MG/VIAL 50 MG/ML, 7ML AMIVANTAMAB-FOR TESTING PURPOSE ONLY | Belgium | India | 21 | |||
30049099 | NCV-FOR CLINICAL TRIAL-PEMETREXED 500MG/VIAL-FOR TESTING PURPOSE ONLY | Belgium | India | 1 | |||
30049099 | NCV-FOR CLINICAL TRIAL-MACITENTAN 37.5MG/PLACEBO-36X12=432 TBAS-FOR TESTING PURPOSE ONLY | Belgium | India | 12 | |||
30049099 | NCV-FOR CLINICAL- MACITENTAN 75MG/PLACEBO-36X12=432 TBAS-FORTESTING PURPOSE ONLY | Belgium | India | 12 | |||
30049099 | INVEGA SUSTENNA 1X75MG SYR 300 PCS | Belgium | India | 45.69 | |||
30049099 | INVEGA SUSTENNA 1X150MG SYR 1000 PCS | Belgium | India | 152.30 | |||
30049099 | FOC WATER FOR INJECTION 100 ML LICENCE VALID UP TO 23 SEP 2024 | Belgium | India | 600 | |||
30049099 | FOC NUMETZAH G19E SOLUTION FOR INJECTION 1000ML LICENCE VALID UP TO 07 JUN 2026 MFG. ER : M/S BAXTER ALLIANC | Belgium | India | 78 | |||
30049099 | TRAVATAN APS OPHTH SOL 0.004% 742340 BATCH VT257F IL/FF-000203 FF-230 VALID DATE 30/06/2025 | Belgium | India | 28014 | |||
30049099 | TRAVATAN APS OPHTH SOL 0.004% - 742340 BATCH-VT257F TRAVOPROST OPHTHALMIC IL/FF-000203 FF-230 VALID DATE 30/06/2025 | Belgium | India | 99536 | |||
30049099 | FOC SOLIVITO N- IV INFUSION, 50 VIALS LICENCE VALID UP TO 17 AUG 2025 MFG. ER : M/S BAXTER ALLIANCE PARK 10ML | Belgium | India | 190 | |||
30049099 | FOC FOSFOMYCIN POWDER FOR SOLUTION FOR INFUSION 4G/VIAL FOMICYT , 200 VIALS LICENCE VALID UP TO 15 MAR 2026MANUFAC | Belgium | India | 200 | |||
30049099 | FOC 07699842 Dabrafenib Capsules 50 milligram mg TAFINLAR 1X120 ST HKP TAFINLAR 50MG | Belgium | India | 2 | |||
30049099 | FOC 903258 Losartan Potassium Tablets 100milligram mg LOORTAN 98 Tbl Loortan 100mg B | Belgium | India | 5 | |||
30049099 | FOC 07699865 Dabrafenib Capsules 75 milligram mg TAFINLAR 1X120 ST HKP TAFINLAR 75MG | Belgium | India | 2 | |||
30049099 | FOC 903279 Losartan Potassium Tablets 50milligram mg LOORTAN 98 Tbl Loortan 50mg B | Belgium | India | 5 | |||
30049099 | N.C.V LIVOCAB LEVOCABASTINE HCL 0.5MG/ML NASAL SPRAY 1BOTTLE=15ML 2985 ML FOR TESTING PURPOSE ONLY | Belgium | India | 199 | |||
30049099 | DENOSUMAB XGEVA 120 MG/1.7ML 1 PER PACK | Belgium | India | 117 | |||
30049099 | NCV-FOR CLINICAL TRIAL- AMIVANTAMAB 350 MG: 50 MG/ML IN A 7ML VIALS-FOR TESTING PURPOSE ONLY | Belgium | India | 10 | |||
30049099 | FLIXOTIDE DISKUS 250 MICROGRAM/DOSIS FLUTICASONE PROPIONATEINHALATION POWDER, 250 MCG BATCH NO.M97D 4500 DOSES F | Belgium | India | 75 | |||
30049099 | FLIXOTIDE DISKUS 250 MICROGRAM/DOSIS FLUTICASONE PROPIONATEINHALATION POWDER, 250 MCG BATCH NO.M97D 4500 DOSES F | Belgium | India | 75 | |||
30049099 | TRAVOPROST 0.004% 2.5ML-IN 742410 BATCH-VP850M IL/FF-000203FF-230 VALID DATE 30/06/2025 | Belgium | India | 33208 | |||
30049099 | TRAVOPROST 0.004% 2.5ML-IN 742410 BATCH-VP850M IL/FF-000203FF-230 VALID DATE 30/06/2025 | Belgium | India | 34322 |
HSN Code | Product Description | Origin | Destination | Qty. | Importer | Exporter |
---|
30049099 | TABLETS >> JNJ-54861911-AAA 25MG TABLETS IMP TEST LIC. NO. T-8848-13 DT 30.09.13 FOR R & D UNIT ONLY | Belgium | India | 2000 | |||
30049099 | INDIA >> TRPAT INDIA DUROGESIC D-TRANS 50MU 3 TRPAT INDIA | Belgium | India | 75 | |||
30049099 | OLICLINOMEL >> OLICLINOMEL N7-1000 E 1500 ML | Belgium | India | 772 | |||
30049099 | CLINICAL >> CLINICAL TRIAL JNJ28431754 100MG , 300MG-PLACEBO PER 1KIT = 55 CAPSULE IMPT LIC.#.101-CT-BE-13 DT.08-07-2013 FOR CLINICAL TRIAL USE O | Belgium | India | 44 | |||
30049099 | CLINICAL >> CLINICAL TRIAL JNJ28431754 100MG , 300MG-PLACEBO PER 1KIT = 55 CAPSULE IMPT LIC.#.101-CT-BE-13 DT.08-07-2013 FOR CLINICAL TRIAL USE O | Belgium | India | 22 | 60 More Columns Available | ||
30049099 | OLICLINOMEL >> OLICLINOMEL N7-1000 E 1500 ML | Belgium | India | 228 | |||
30049099 | INDIA >> SYR INDIA INV.EGA SUSTENNA 1X100MG SYR.INDIA | Belgium | India | 200 | |||
30049099 | SOLUTION >> VIAL SOLUTION NOOTROPIL 2G PER VIAL SOLUTION FOR INJECTIONS IMP TEST LICNO.T-6587-13 DT.03.08.2013 FOR TESTING PURPOSE ONLY | Belgium | India | 79 | |||
30049099 | TABLET >> CITRIZINE TABLET ZYRTEC CITRIZINE TABLET 100MG IMP TEST LIC NO.T-5687-13 DT.10.07.2013 FOR TESTING PURPOSE ONLY | Belgium | India | 920 | |||
30049099 | TABLETS >> ATARAX 10MG FILM-COATED TABLETS IMP TEST LIC NO.T-6587-13 DT.03.08.2013 FOR TESTING PURPOSE ONLY | Belgium | India | 2275 | |||
30049099 | TABLETS >> ATARAX 10MG FILM-COATED TABLETS IMP TEST LIC NO.T-6587-13 DT.03.08.2013 FOR TESTING PURPOSE ONLY | Belgium | India | 5711 | |||
30049099 | SOLUTION >> ORAL SOLUTION XYZAL LEVOCETIRIZINE ORAL SOLUTION 0.5MG-ML T-11260-13 DT.05.12.2013 FOR TESTING PUROPSE ONLY | Belgium | India | 19 | |||
30049099 | SOLUTION >> ORAL SOLUTION ZYRTEC CETRIZINE ORAL SOLUTION 1MG-ML T-11260-13 DT.05.12.2013 FOR TESTING PUROPSE ONLY | Belgium | India | 15 | |||
30049099 | INDIA >> VIAL INDIA DACOGEN IV 1X50MG VIAL INDIA | Belgium | India | 18 | |||
30049099 | TABLETS >> CANDESARTAN TABLETS ATACAND CANDESARTAN TABLETS 8MG 56 TABLETS-PACK ASTRA ZE - NECA LICENCENO.T-4088-14.DTD: 22-05-2014 SAMPLE FOR R & D | Belgium | India | 2 | |||
30049099 | OLICLINOMEL >> OLICLINOMEL N4-550 E 1000ML | Belgium | India | 42 | |||
30049099 | INDIA >> TRPAT INDIA DUROGESIC D-TRANS 50MU 3 TRPAT INDIA | Belgium | India | 7000 | |||
30049099 | PIPAMPERONE >> DIPIPERON PIPAMPERONE DIPIPERON PIPAMPERONE HCL 4MG-ML IMP TEST LIC NO.T-1516-14DT.25.03.2014 FOR TESTING PURPOSE ONLY | Belgium | India | 32 | |||
30049099 | DROPS >> ORAL DROPS ZYRTEC ORAL DROPS CETRIZINE 5MG-ML T-11260-13 DT.05.12.2013 FOR TESTING PUROPSE ONLY | Belgium | India | 15 | |||
30049099 | INDIA >> SYR INDIA INV.EGA SUSTENNA 1X75MG SYR. INDIA | Belgium | India | 200 | |||
30049099 | SOLUTION >> ORAL SOLUTION ZYRTEC CETRIZINE ORAL SOLUTION 1MG-ML T-11260-13 DT.05.12.2013 FOR TESTING PUROPSE ONLY | Belgium | India | 30 | |||
30049099 | INDIA >> VIAL INDIA VELCADE 1X3.5MG VIAL INDIA | Belgium | India | 288 | |||
30049099 | CLINDAMYCIN >> DALACIN C SSOL 600MG 1X4 ML LIST 3 SR NO.18 CLINDAMYCIN | Belgium | India | 127440 | |||
30049099 | INDIA >> SYR INDIA INV.EGA SUSTENNA 1X75MG SYR. INDIA | Belgium | India | 200 | |||
30049099 | CLINICAL >> CLINICAL TRIAL JNJ28431754 100MG , 300MG-PLACEBO PER 1KIT = 55 CAPSULE IMPT LIC.#.101-CT-BE-13 DT.08-07-2013 FOR CLINICAL TRIAL USE O | Belgium | India | 49 | |||
30049099 | CLINICAL >> CLINICAL TRIAL JNJ28431754 100MG , 300MG-PLACEBO PER 1KIT = 55 CAPSULE IMPT LIC.#.101-CT-BE-13 DT.08-07-2013 FOR CLINICAL TRIAL USE O | Belgium | India | 127 | |||
30049099 | SOLUTION >> RITONAVIR 80MG-ML 1X90ML SOLUTION FOR ORAL USE | Belgium | India | 3 | |||
30049099 | DROPS >> ORAL DROPS ZYRTEC ORAL DROPS CETRIZINE 5MG-ML T-11260-13 DT.05.12.2013 FOR TESTING PUROPSE ONLY | Belgium | India | 68 | |||
30049099 | BOTTLE >> BOTTLE HALOPERIDOL HALDOL BOTTLE HALOPERIDOL 2 MG-ML 1BOTTLE-100ML IMP TEST LIC NO.T-1562-14 DT.01.04.2014 FOR TESTING PURPOSE ONLY | Belgium | India | 41 | |||
30049099 | SUSPENSION >> INJECTABLE SUSPENSION PALIPERIDONE PALMITATE INV.EGA SUSTENNA 117 MG FOR EXTENDED RELEASE INJECTABLE SUSPENSION 30 PREFILLED SINGLE-USE SYRI | Belgium | India | 30 | |||
30049099 | OLICLINOMEL >> OLICLINOMEL N4-550 E 2000ML | Belgium | India | 1040 | |||
30049099 | TABLETS >> TABLETS GLIBENCLAMID DAONIL 5MG -100 TABLETS -GLIBENCLAMID LICENCE NO:T9361-13 D - TD:21-10-13 SAMPLE FOR R & D PURPOSE ONLY | Belgium | India | 1 | |||
30049099 | TABLETS >> LEVOFLOXACIN TABLETS AGILEV LEVOFLOXACIN TABLETS 500MG-5 TABLETS SAMPLE FOR R & - D PURPOSE ONLY | Belgium | India | 63 | |||
30049099 | CLINDAMYCIN >> DALACIN C SSOL 300MG 1X2ML AMP LIST 3 SR NO.18 CLINDAMYCIN | Belgium | India | 108688 | |||
30049099 | OPTH >> XALATAN OPTH XALATAN OPTH 1 X 2.5ML LATANOPROST - LIST 3 SL NO.46 | Belgium | India | 23070 | |||
30049099 | SUSTENNA >> INV.EGA SUSTENNA 1X150MG SYR | Belgium | India | 200 | |||
30049099 | SUSPENSION >> DOMPERIDONE SUSPENSION MOTILIUM BOTTLE -DOMPERIDONE SUSPENSION 1MG-ML UNDER TLIC NO.T-1567-14 DT.05.09.2014 FOR TESTING PURPOSE ONLY | Belgium | India | 60 | |||
30049099 | INDIA >> SYR INDIA INV.EGA SUSTENNA 1X100MG SYR. INDIA | Belgium | India | 610 | |||
30049099 | MEDROL >> SOLU MEDROL SOLU-MEDROL AOV 40MG 1ML LIST NO:3 SR NO 51 METHYLPRED | Belgium | India | 139146 | |||
30049099 | SUSPENSION >> TMC 114 DARUNAVIR 100MG-ML 1X200 ML SUSPENSION FOR ORAL USE | Belgium | India | 8 | |||
30049099 | TABLET >> TABLET INTELENCE TABLET INTELENCE ETRAVIRINE 100MG - 360 TABS. IN 3 KITS-FO - R PERSONAL USE ONLY PERISHABLE CARGO | Belgium | India | 3 | |||
30049099 | CLINICAL >> CLINICAL TRIAL JNJ28431754 100MG , 300MG-PLACEBO PER 1KIT = 55 CAPSULE IMPT LIC.#.101-CT-BE-13 DT.08-07-2013 FOR CLINICAL TRIAL USE O | Belgium | India | 167 | |||
30049099 | CLINICAL >> CLINICAL TRIAL JNJ28431754 100MG , 300MG-PLACEBO PER 1KIT = 55 CAPSULE IMPT LIC.#.101-CT-BE-13 DT.08-07-2013 FOR CLINICAL TRIAL USE O | Belgium | India | 117 | |||
30049099 | TUBES >> TUBES KETOCONAZOLE NIZORAL 20MG-G TUBES KETOCONAZOLE IMP TEST LIC NO.T-2484-13 DT.12.04.2013 FOR TESTING PURPOSE ONLY | Belgium | India | 10 | |||
30049099 | CLINICAL >> CLINICAL TRIAL JNJ28431754 100MG , 300MG-PLACEBO PER 1KIT = 55 CAPSULE IMPT LIC.#.101-CT-BE-13 DT.08-07-2013 FOR CLINICAL TRIAL USE O | Belgium | India | 46 | |||
30049099 | CLINICAL >> CLINICAL TRIAL JNJ28431754 100MG , 300MG-PLACEBO PER 1KIT = 55 CAPSULE IMPT LIC.#.101-CT-BE-13 DT.08-07-2013 FOR CLINICAL TRIAL USE O | Belgium | India | 30 | |||
30049099 | CLINICAL >> CLINICAL TRIAL JNJ28431754 100MG , 300MG-PLACEBO PER 1KIT = 55 CAPSULE IMPT LIC.#.101-CT-BE-13 DT.08-07-2013 FOR CLINICAL TRIAL USE O | Belgium | India | 20 | |||
30049099 | SOLUTION >> ORAL SOLUTION XYZAL LEVOCETRIZINE ORAL SOLUTION 0.5MG-ML IMP TEST LIC NO.T-11260-13 DT.05.12.2013 FOR TESTING PURPOSE ONLY | Belgium | India | 14 | |||
30049099 | CLINICAL >> CLINICAL TRIAL JNJ28431754 100MG , 300MG-PLACEBO PER 1KIT = 55 CAPSULE IMPT LIC.#.101-CT-BE-13 DT.08-07-2013 FOR CLINICAL TRIAL USE O | Belgium | India | 24 | |||
30049099 | CLINICAL >> CLINICAL TRIAL JNJ28431754 100MG , 300MG-PLACEBO PER 1KIT = 55 CAPSULE IMPT LIC.#.101-CT-BE-13 DT.08-07-2013 FOR CLINICAL TRIAL USE O | Belgium | India | 12 | |||
30049099 | N.C.V ATICAPRANT 10MG FILM COTED TABLETS JNJ-67953964-AAA G020 35 CT BLISTER81 BLISTERSFOR R&D UNIT ONLY | Belgium | India | 2835 | |||
30049099 | DUPILUMAB INJECTION DUPIXENT-200MG 175MG/ML-2X3=6 PENS-FOR TEST OR ANALYSIS PURPOSE ONLY | Belgium | India | 3 | |||
30049099 | PEMBROLIZUMAB INJECTION KEYTRUDA-25MG/ML ML-FOR TEST ORANALYSIS PURPOSE ONLY | Belgium | India | 6 | |||
30049099 | N.C.V LIVOCAB LEVOCABASTINE HCL 0.5 MG/ML NASAL SPRAY 1BOTTLE =15 ML 1500.ML FOR TESTING PURPOSE ONLY | Belgium | India | 100 | |||
30049099 | NCV-FOR CLINICAL TRIAL-AMIVANTAMAB 350 MG 50MG/ML IN A 7ML VIAL-FOR TESTING PURPOSE ONLY | Belgium | India | 10 | |||
30049099 | INVEGA SUSTENNA 1X150MG SYR 600 PCS | Belgium | India | 84 | |||
30049099 | INVEGA SUSTENNA 1X100MG SYR 1000 PCS | Belgium | India | 75.20 | |||
30049099 | NCV-FOR CLINICAL TRIAL-MACITENTAN 75MG/PLACEBO-36X6=216 TABS-FOR TESTING PURPOSE ONLY | Belgium | India | 6 | |||
30049099 | NCV-FOR CLINICAL TRIAL-MACITENTAN 37.5MG/PLACEBO-36X1=36 TABS-FOR TESTING PURPOSE ONLY | Belgium | India | 1 | |||
30049099 | NCV-FOR CLINICAL TRIAL-MACITENTAN 10MG/PLACEBO-36X7=252 TABS-FOR TESTING PURPOSE ONLY | Belgium | India | 7 | |||
30049099 | N.C.V NIZORAL 20MG/G CERAM 1 TUBE= 10G 840G FOR TESTING PURPOSE ONLY | Belgium | India | 84 | |||
30049099 | NEPAFENAC OPHTHALMIC SUSPENSION 0.3% W/V 3MG/ML LDPE 3ML XIN 753761 BATCH-VT610A IL/FF-000287 RC/FF-002118 VALID DAT | Belgium | India | 18318 | |||
30049099 | NEPAFENAC OPHTHALMIC SUSPENSION 0.3% W/V 3MG/ML LDPE 3ML XIN 753761 BATCH-VT610A IL/FF-000287 RC/FF-002118 VALID DAT | Belgium | India | 18318 | |||
30049099 | NEPAFENAC OPHTHALMIC SUSPENSION 0.3% W/V 3MG/ML LDPE 3ML XIN 753761 BATCH-VT610A IL/FF-000287 RC/FF-002118 VALID DAT | Belgium | India | 18318 | |||
30049099 | NEPAFENAC OPHTHALMIC SUSPENSION 0.3% W/V 3MG/ML LDPE 3ML XIN 753761 BATCH-VT610A IL/FF-000287 RC/FF-002118 VALID DAT | Belgium | India | 18318 | |||
30049099 | NEPAFENAC OPHTHALMIC SUSPENSION 0.3% W/V 3MG/ML LDPE 3ML XIN 753761 BATCH-VT610A IL/FF-000287 RC/FF-002118 VALID DAT | Belgium | India | 18318 | |||
30049099 | ONE ALPHA1MCG/ 30 X 23 PACKS ALPHACALCIDOL CAPSULE FOR RESERACH AND ANALYSIS PURPOSE ONLY | Belgium | India | 690 | |||
30049099 | CARTON CONTAINS 2 BLISTERS. BLISTER CONTAINS 15 TABLETS OF 25 MG EXEMESTANE. FOR ORAL USE ONLY. LOT: D594588 TOTAL 25 | Belgium | India | 68 | |||
30049099 | CARTON CONTAINS 2 BLISTERS. BLISTER CONTAINS 14 TABLETS OF 1 MG ANASTROZOLE. FOR ORAL USE ONLY. LOT: D534509 TOTAL QU | Belgium | India | 176 | |||
30049099 | N.C.V LAZERTINIB JNJ-73841937-ZCY 80MG TABLETS 60 X 56CT BOTTLE FOR R&D UNIT ONLY | Belgium | India | 3360 | |||
30049099 | METHYLPREDNISOLONE TABLET 32 MG MEDROL PACK SIZE: 20 TABLETS | Belgium | India | 5 | |||
30049099 | N.C.V LAZERTINIB JNJ-73841937-ZCY 240MG TABLETS 30 X 98CT BOTTLEFOR R&D UNIT ONLY | Belgium | India | 2940 | |||
30049099 | NCV-FOR CLINICAL TRIAL-MACITENTAN 10MG-36X4=144 TABS-FOR TESTING PURPOSE ONLY | Belgium | India | 4 | |||
30049099 | NCV-FOR CLINICAL TRIAL-AMIVANTAMAB 350MG/VIAL 50 MG/ML, 7ML AMIVANTAMAB-FOR TESTING PURPOSE ONLY | Belgium | India | 4 | |||
30049099 | ODEFSEY EMTRICITABINE,RILPIVIRINE & TENOFOVIR ALAFENAMIDE 200/25/25MG FILM-COTED TAB 6PACKSX30 COUNT 180 TAB FOC | Belgium | India | 6 | |||
30049099 | NCV-FOR CLINICAL TRIAL-MACITENTAN 10MG/PLACEBO-36X12=432 TABS-FOR TESTING PURPOSE ONLY | Belgium | India | 12 | |||
30049099 | NCV-FOR CLINICAL TRIAL-LAZERTINB 80 MILLIGRAM MG-72X4=288TABS-FOR TESTING PURPOSE ONLY | Belgium | India | 4 | |||
30049099 | NCV-FOR CLINICAL TRIAL-AMIVANTAMAB 350MG/VIAL 50 MG/ML, 7ML AMIVANTAMAB-FOR TESTING PURPOSE ONLY | Belgium | India | 21 | |||
30049099 | NCV-FOR CLINICAL TRIAL-PEMETREXED 500MG/VIAL-FOR TESTING PURPOSE ONLY | Belgium | India | 1 | |||
30049099 | NCV-FOR CLINICAL TRIAL-MACITENTAN 37.5MG/PLACEBO-36X12=432 TBAS-FOR TESTING PURPOSE ONLY | Belgium | India | 12 | |||
30049099 | NCV-FOR CLINICAL- MACITENTAN 75MG/PLACEBO-36X12=432 TBAS-FORTESTING PURPOSE ONLY | Belgium | India | 12 | |||
30049099 | INVEGA SUSTENNA 1X75MG SYR 300 PCS | Belgium | India | 45.69 | |||
30049099 | INVEGA SUSTENNA 1X150MG SYR 1000 PCS | Belgium | India | 152.30 | |||
30049099 | FOC WATER FOR INJECTION 100 ML LICENCE VALID UP TO 23 SEP 2024 | Belgium | India | 600 | |||
30049099 | FOC NUMETZAH G19E SOLUTION FOR INJECTION 1000ML LICENCE VALID UP TO 07 JUN 2026 MFG. ER : M/S BAXTER ALLIANC | Belgium | India | 78 | |||
30049099 | TRAVATAN APS OPHTH SOL 0.004% 742340 BATCH VT257F IL/FF-000203 FF-230 VALID DATE 30/06/2025 | Belgium | India | 28014 | |||
30049099 | TRAVATAN APS OPHTH SOL 0.004% - 742340 BATCH-VT257F TRAVOPROST OPHTHALMIC IL/FF-000203 FF-230 VALID DATE 30/06/2025 | Belgium | India | 99536 | |||
30049099 | FOC SOLIVITO N- IV INFUSION, 50 VIALS LICENCE VALID UP TO 17 AUG 2025 MFG. ER : M/S BAXTER ALLIANCE PARK 10ML | Belgium | India | 190 | |||
30049099 | FOC FOSFOMYCIN POWDER FOR SOLUTION FOR INFUSION 4G/VIAL FOMICYT , 200 VIALS LICENCE VALID UP TO 15 MAR 2026MANUFAC | Belgium | India | 200 | |||
30049099 | FOC 07699842 Dabrafenib Capsules 50 milligram mg TAFINLAR 1X120 ST HKP TAFINLAR 50MG | Belgium | India | 2 | |||
30049099 | FOC 903258 Losartan Potassium Tablets 100milligram mg LOORTAN 98 Tbl Loortan 100mg B | Belgium | India | 5 | |||
30049099 | FOC 07699865 Dabrafenib Capsules 75 milligram mg TAFINLAR 1X120 ST HKP TAFINLAR 75MG | Belgium | India | 2 | |||
30049099 | FOC 903279 Losartan Potassium Tablets 50milligram mg LOORTAN 98 Tbl Loortan 50mg B | Belgium | India | 5 | |||
30049099 | N.C.V LIVOCAB LEVOCABASTINE HCL 0.5MG/ML NASAL SPRAY 1BOTTLE=15ML 2985 ML FOR TESTING PURPOSE ONLY | Belgium | India | 199 | |||
30049099 | DENOSUMAB XGEVA 120 MG/1.7ML 1 PER PACK | Belgium | India | 117 | |||
30049099 | NCV-FOR CLINICAL TRIAL- AMIVANTAMAB 350 MG: 50 MG/ML IN A 7ML VIALS-FOR TESTING PURPOSE ONLY | Belgium | India | 10 | |||
30049099 | FLIXOTIDE DISKUS 250 MICROGRAM/DOSIS FLUTICASONE PROPIONATEINHALATION POWDER, 250 MCG BATCH NO.M97D 4500 DOSES F | Belgium | India | 75 | |||
30049099 | FLIXOTIDE DISKUS 250 MICROGRAM/DOSIS FLUTICASONE PROPIONATEINHALATION POWDER, 250 MCG BATCH NO.M97D 4500 DOSES F | Belgium | India | 75 | |||
30049099 | TRAVOPROST 0.004% 2.5ML-IN 742410 BATCH-VP850M IL/FF-000203FF-230 VALID DATE 30/06/2025 | Belgium | India | 33208 | |||
30049099 | TRAVOPROST 0.004% 2.5ML-IN 742410 BATCH-VP850M IL/FF-000203FF-230 VALID DATE 30/06/2025 | Belgium | India | 34322 |
Volza's data of India HSN Code 30049099 imports allows you to study detailed data with buyer supplier names for last 10 years.
Volza's data of India HSN Code 30049099 imports helps you create a import strategy from detailed trade data with buyer supplier names, price, volume for last 10 years.
You can find India HSN Code 30049099 import market intelligence of last 10 years with buyer, supplier, price and volume from Volza.com
You can find New markets for HSN Code 30049099 imports from Volza Country wise market report of last 10 years with growth rate, buyer, supplier, price and volume.
Major products related with HSN Code 30049099 are Intravenous Amino Acid, Anti Aging Cream, For Eye Contour Cream, Hormone Injection, Clavulanic Acid.
Top 1 HSN codes for HSN Code 30049099 are HSN Code 30049099 , You can check for details at https://www.volza.com/hs-codes.
Volza's data of India HSN Code 30049099 imports from Belgium is 100% authentic as it is based on actual import export shipments and is collected globally from over 20,000 ports from over 70+ Countries.
Data of India HSN Code 30049099 imports from Belgium contains strategic information and is very useful for importers and exporters who want to expand global trade, improve supply chain of HSN Code 30049099, find economical vendors, new buyers and fast growing markets.
Data of India HSN Code 30049099 imports from Belgium contains date of shipment, Name and contact details of importer, exporter, product description, price, quantity, country & port of origin, country & port of destination and many other fields.
We update information of India HSN Code 30049099 imports from Belgium every month.
India wide 5,720 of HSN Code 30049099 shipments were imported from Belgium.
You can download latest data of Jan-2024 of India HSN Code 30049099 imports from Belgium here
You can download Volza India HSN Code 30049099 import data with names of buyers and suppliers.
There are two options to Subscribe, Online Access starts at $1500 and reports from Volza Consulting starts at $1000.
Volza Sales team will be happy to answer your questions, you can reach us at [email protected] or +1-302 786 5213.
Online |
---|
Mode Do it yourself |
Availiblity Instant access |
Cost Access 209+ countries data |
Payment Instant Online |
Data Format Excel |
View More |
Volza Consulting |
---|
Mode Customer Order |
Availiblity Starts within 48 hours |
Cost $1000 |
Payment Online and other modes |
Data Format Excel, SQL, MSAcess & Custom |
View More |
Support
Important Links
Partners
Trade Data
About Us
Partners